Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
495 INR | +0.54% | -1.82% | +1.19% |
Mar. 29 | Aarti Drugs Limited Announces Executive Cessation | CI |
Jan. 31 | Aarti Drugs Begins Manufacturing Dermatology Products in Tarapur, India Facility | MT |
Sales 2024 * | 26.12B 313M | Sales 2025 * | 29.48B 354M | Capitalization | 45.62B 547M |
---|---|---|---|---|---|
Net income 2024 * | 1.73B 20.76M | Net income 2025 * | 2.52B 30.18M | EV / Sales 2024 * | 1.75 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.55 x |
P/E ratio 2024 * |
26.5
x | P/E ratio 2025 * |
18.2
x | Employees | 1,003 |
Yield 2024 * |
0.95% | Yield 2025 * |
1.37% | Free-Float | 36.93% |
Latest transcript on Aarti Drugs Limited
1 day | +0.54% | ||
1 week | -1.82% | ||
Current month | +13.98% | ||
1 month | +11.01% | ||
3 months | -7.02% | ||
6 months | -9.17% | ||
Current year | +1.19% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 85-01-04 | |
Adhish P. Patil
DFI | Director of Finance/CFO | 41 | 12-07-05 |
Rushikesh Deole
CMP | Compliance Officer | - | 19-04-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 85-01-04 | |
Director/Board Member | 61 | 87-01-01 | |
Director/Board Member | 60 | 95-09-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 495 | +0.54% | 104,914 |
24-04-18 | 492.4 | -0.49% | 110,702 |
24-04-16 | 494.8 | +0.85% | 81,950 |
24-04-15 | 490.6 | -2.70% | 146,188 |
24-04-12 | 504.2 | -0.74% | 124,404 |
Delayed Quote NSE India S.E., April 19, 2024 at 07:43 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.60% | 672B | |
+24.08% | 550B | |
-5.63% | 351B | |
+15.37% | 317B | |
+7.38% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.69% | 144B | |
-6.63% | 141B |
- Stock Market
- Equities
- AARTIDRUGS Stock
- AARTIDRUGS Stock